|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
|
|---|---|---|
| Operating activities | ||
| Net loss | ||
| Adjustments to reconcile net loss to cash used in operating activities: | ||
| Depreciation and amortization | ||
| Non-cash operating lease expense | ||
| Stock-based compensation | ||
| Accretion of debt discount and debt issuance costs | ||
| Accretion of premiums/discounts on marketable securities, net | ||
| Loss (gain) on sale of property and equipment | ||
| Change in fair value of warrant liability | ||
| Gain on sale of equipment | ||
| Change in fair value of investor rights and obligations liability | ||
| Gain on marketable securities | ||
| Changes in operating assets and liabilities | ||
| Prepaid expenses and other current assets | ||
| Other long-term assets | ||
| Accounts payable | ||
| Accrued expenses | ||
| Other long-term liabilities | ||
| Operating lease liabilities | ||
| Net cash used in operating activities | ||
| Investing activities | ||
| Purchase of property and equipment | ||
| Proceeds from sale of equipment | ||
| Purchases of marketable securities | ||
| Sales and maturities of marketable securities | ||
| Net cash used in investing activities | ||
| Financing activities | ||
| Proceeds from issuance of Series C convertible preferred stock, net of offering costs | ||
| Payments of deferred offering costs | ||
| Principal payments on debt | ||
| Proceeds from exercise of stock options | ||
| Proceeds from employee stock purchase plan | ||
| Repurchase of restricted stock | ||
| Net cash provided by financing activities | ||
| Net increase in cash and cash equivalents | ||
| Cash and cash equivalents at beginning of year | ||
| Cash and cash equivalents at end of year | ||
| Income taxes paid | ||
| Interest paid | ||
| Supplemental disclosure of non-cash investing and financing activities | ||
| Deferred offering costs included in accounts payable and accrued liabilities | ||
| Property and equipment purchases included in accounts payable | ||
| Conversion of convertible preferred stock to common stock upon initial public offering | ||
| Reclassification of warrants from liability to equity | ||
| Reclassification of deferred offering costs paid in prior year to equity |
Loading...
